Collplant Biotechnologies Ltd (CLGN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.57
• Market Cap: $7.55M
• EPS: $-1.03
• 52-Week High: $4.98
• 52-Week Low: $0.55

Market Sentiment

Collplant Biotechnologies Ltd currently has a Bullish sentiment score of 0.41.

About Collplant Biotechnologies Ltd

CollPlant Biotechnologies Ltd. is a pioneering company at the forefront of aesthetic and regenerative medicine, based in Rehovot, Israel, with a strong presence in key markets including the United States, Canada, and Europe. The company specializes in cutting-edge three-dimensional (3D) bioprinting technologies for creating tissues and organs, leveraging its proprietary collagen-based solutions to transform treatment modalities in these fields. By advancing medical aesthetics and regenerative...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Collplant Biotechnologies Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CLGN pay dividends?

Collplant Biotechnologies Ltd (CLGN) does not currently pay a regular dividend.

What is CLGN's market cap?

Collplant Biotechnologies Ltd (CLGN) has a market capitalization of $7.55M with a current stock price of $0.57.